| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NRG1 mRNA" | 27071940 |
| C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "NFE2L2 gene mutant form inhibits the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of NRG1 mRNA]" | 27071940 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of NRG1 mRNA" | 28903501 |
| C490166 | 1-(4-methoxyphenyl)piperazine | 1-(4-methoxyphenyl)piperazine results in increased expression of NRG1 mRNA | 26821219 |
| C051246 | 1-methylanthracene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NRG1 mRNA | 28329830 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased expression of NRG1 mRNA | 19041380 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "ERBB3 affects the reaction [NRG1 results in decreased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine]" | 19509167 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "NRG1 protein affects the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased phosphorylation of AKT1 protein]" | 19509167 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "NRG1 protein promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased phosphorylation of ERBB3 protein]" | 19509167 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "NRG1 results in decreased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine" | 19509167 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NRG1 mRNA | 19933214 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl affects the expression of NRG1 mRNA" | 21703328 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRG1 mRNA" | 23146750 |
| C029141 | 2,2,5,7,8-pentamethyl-1-hydroxychroman | "2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of NRG1 mRNA" | 21920950 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | NRG1 protein alternative form inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | 15231676 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | NRG1 protein alternative form inhibits the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | 15231676 |
| C488185 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide | "NRG1 protein alternative form inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]" | 15231676 |
| C488185 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide | "NRG1 protein alternative form inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]" | 15231676 |
| C013186 | 2,3-pentanedione | "2,3-pentanedione results in increased expression of NRG1 mRNA" | 25710175 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of NRG1 mRNA" | 23146750 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA]" | 21851831 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of NRG1 mRNA" | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LHB protein results in decreased expression of NRG1 mRNA] | 23071612 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP10 protein]] | 19801490 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP2 protein]] | 19801490 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] | 19801490 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP5 protein]] | 19801490 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein]] | 19801490 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | 19801490 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of NRG1 mRNA" | 21346803 |
| C019499 | 2-nitrofluorene | 2-nitrofluorene results in increased expression of NRG1 mRNA | 14600272|1589037 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "NRG1 results in decreased susceptibility to 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol" | 20701826 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NRG1 mRNA" | 19692669|2095900 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NRG1 mRNA | 14600272|1589037 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NRG1 mRNA | 17562736 |
| D000082 | Acetaminophen | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of NRG1 gene | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of NRG1 mRNA | 14600272|1589037 |
| D000393 | Air Pollutants | Air Pollutants analog results in increased expression of NRG1 mRNA | 21757418 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NRG1 mRNA | 16483693 |
| D000726 | Androgen Antagonists | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | 15231676 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] | 15231676 |
| D001151 | Arsenic | Arsenic affects the expression of NRG1 protein | 24675094 |
| D001151 | Arsenic | Arsenic affects the methylation of NRG1 gene | 25304211 |
| D001151 | Arsenic | Arsenic results in increased expression of NRG1 mRNA | 19945496 |
| D001151 | Arsenic | Arsenic results in decreased expression of NRG1 mRNA | 24019935 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NRG1 mRNA | 22521957 |
| C015001 | arsenite | arsenite results in decreased expression of NRG1 mRNA | 23974009 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite affects the expression of NRG1 mRNA" | 24160326 |
| C547126 | AZM551248 | AZM551248 results in increased expression of NRG1 mRNA | 22323515 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA | 18164116 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NRG1 mRNA" | 19150397 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NRG1 mRNA" | 20382639 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [KU-32 compound inhibits the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein]] | 23240583 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein] | 23240583 |
| D004958 | Estradiol | ESR1 protein affects the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| D004958 | Estradiol | [NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein | 26502914 |
| D004958 | Estradiol | Raloxifene Hydrochloride inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| D004958 | Estradiol | Estradiol results in decreased expression of NRG1 mRNA | 20068009 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of NRG1 mRNA | 27685785 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | 15231676 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] | 15231676 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of NRG1 promoter | 27271280 |
| C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA | 25607892 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of NRG1 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of NRG1 gene | 28505145 |
| C038091 | butylparaben | [butylparaben co-treated with NRG1 protein] promotes the reaction [ESR1 protein binds to MYC enhancer] | 26502914 |
| C038091 | butylparaben | butylparaben promotes the reaction [NRG1 protein results in increased expression of MYC mRNA] | 26502914 |
| C038091 | butylparaben | [NRG1 protein co-treated with butylparaben] results in increased expression of MYC protein | 26502914 |
| C038091 | butylparaben | NRG1 protein promotes the reaction [butylparaben results in increased expression of MYC mRNA] | 26502914 |
| C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA | 25607892 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of NRG1 mRNA | 26079696 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of NRG1 mRNA | 17720352 |
| D002104 | Cadmium | Cadmium results in increased expression of NRG1 mRNA | 21120746 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of NRG1 mRNA | 12160620 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of NRG1 mRNA | 22110744 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased methylation of NRG1 promoter | 22457795 |
| D002235 | Carbofuran | Carbofuran results in decreased expression of NRG1 mRNA | 28982980 |
| D000068579 | Celecoxib | Celecoxib inhibits the reaction [IL1B protein results in increased expression of and results in increased secretion of NRG1 protein] | 16357062 |
| D000068579 | Celecoxib | Celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA] | 16357062 |
| D000068579 | Celecoxib | Dinoprostone inhibits the reaction [Celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA]] | 16357062 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA | 20938992 |
| D003024 | Clozapine | Clozapine results in increased expression of NRG1 mRNA | 19502011 |
| D003024 | Clozapine | NRG1 protein affects the susceptibility to Clozapine | 15706234 |
| D003024 | Clozapine | Clozapine affects the expression of NRG1 protein | 18184445 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of NRG1 mRNA | 19320972 |
| D005576 | Colforsin | [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA | 21047912 |
| D005576 | Colforsin | U 0126 inhibits the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA] | 21047912 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of NRG1 mRNA | 19549813 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of NRG1 mRNA | 21527772 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of NRG1 mRNA | 20106945|2214713 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of NRG1 mRNA | 23640034 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of NRG1 mRNA | 23914054 |
| D013759 | Dronabinol | NRG1 gene SNP affects the susceptibility to Dronabinol | 20582876 |
| D013759 | Dronabinol | NRG1 affects the susceptibility to Dronabinol | 17333138|1790552 |
| D013759 | Dronabinol | [NRG1 affects the susceptibility to Dronabinol] which affects the expression of FOS protein | 17905522 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of NRG1 mRNA] | 27941970 |
| D003993 | Dibutyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| D003993 | Dibutyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| D003633 | Dichlorodiphenyl Dichloroethylene | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| D003633 | Dichlorodiphenyl Dichloroethylene | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of NRG1 mRNA | 25016146 |
| D004051 | Diethylhexyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| D004051 | Diethylhexyl Phthalate | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of NRG1 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA | 18164116 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NRG1 mRNA | 15890375 |
| C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased expression of NRG1 mRNA | 20886546 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of NRG1 mRNA | 14600272|1589037 |
| C547156 | dimethylthioarsinic acid | dimethylthioarsinic acid results in decreased expression of NRG1 mRNA | 19945496 |
| D004237 | Diuron | Diuron results in decreased expression of NRG1 mRNA | 25152437 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NRG1 mRNA | 28940058 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of AKT1 protein] | 15833803 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of ERBB2 protein] | 15833803 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of MAPK1 protein] | 15833803 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of MAPK3 protein] | 15833803 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of RPS6KB1 protein] | 15833803 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin results in decreased expression of TNNC1 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin results in decreased expression of TNNI3 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin results in decreased expression of TNNT2 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein affects the susceptibility to Doxorubicin | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP10 protein]] | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP2 protein]] | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP5 protein]] | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein]] | 19801490 |
| D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | 19801490 |
| D004317 | Doxorubicin | AKT1 protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 protein]] | 19801490 |
| D004317 | Doxorubicin | AKT1 protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 protein]] | 19801490 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NRG1 protein alternative form | 17308081 |
| D004317 | Doxorubicin | ERBB2 protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 protein]] | 19801490 |
| D004317 | Doxorubicin | ERBB2 protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 protein]] | 19801490 |
| D004317 | Doxorubicin | MTOR protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 protein]] | 19801490 |
| D004317 | Doxorubicin | MTOR protein promotes the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 protein]] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein affects the reaction [Doxorubicin results in increased degradation of TNNI3 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein alternative form inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 protein] | 17005195 |
| D004317 | Doxorubicin | NRG1 protein alternative form inhibits the reaction [Doxorubicin results in decreased expression of GSR mRNA] | 17005195 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 mRNA] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNI3 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 mRNA] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of EIF4EBP1 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of EIF4G1 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of MTOR protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of RPS6KB2 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of RPS6 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP10 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP2 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP5 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | 19801490 |
| D004317 | Doxorubicin | NRG1 protein inhibits the reaction [Doxorubicin results in increased ubiquitination of TNNI3 protein] | 19801490 |
| C118739 | entinostat | entinostat results in decreased expression of NRG1 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA | 25607892 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of NRG1 mRNA | 20346928 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NRG1 mRNA | 22079256 |
| C109476 | epoxiconazole | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| C109476 | epoxiconazole | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| C540355 | fenamidone | fenamidone results in increased expression of NRG1 mRNA | 27029645 |
| C007738 | fluoranthene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NRG1 mRNA | 28329830 |
| D005472 | Fluorouracil | NRG1 protein affects the susceptibility to Fluorouracil | 16217747 |
| D005485 | Flutamide | Flutamide results in decreased expression of NRG1 mRNA | 24793618 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA | 20938992 |
| D004397 | Fonofos | Fonofos results in increased methylation of NRG1 promoter | 22847954 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| C039281 | furan | furan results in increased expression of NRG1 mRNA | 24183702 |
| C039281 | furan | furan results in increased expression of NRG1 mRNA | 25539665|2619464 |
| C056507 | gemcitabine | gemcitabine results in increased expression of NRG1 mRNA | 17039268 |
| D005947 | Glucose | MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D005947 | Glucose | MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D005947 | Glucose | [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose | 14711829 |
| D005947 | Glucose | NRG1 protein results in increased transport of Glucose | 14711829 |
| D005947 | Glucose | PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D005947 | Glucose | PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D005947 | Glucose | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D006220 | Haloperidol | Haloperidol results in increased expression of NRG1 protein | 18184445|2696161 |
| D006861 | Hydrogen Peroxide | NRG1 protein alternative form inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] | 17005195 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of NRG1 mRNA | 21396975 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of NRG1 mRNA | 28201806 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of NRG1 mRNA | 24796395|2675264 |
| D007649 | Ketamine | Ketamine results in decreased expression of NRG1 mRNA | 20000043 |
| C581040 | KU-32 compound | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [KU-32 compound inhibits the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein]] | 23240583 |
| C581040 | KU-32 compound | KU-32 compound inhibits the reaction [NRG1 protein results in decreased expression of MPZ protein] | 23240583 |
| C581040 | KU-32 compound | KU-32 compound inhibits the reaction [NRG1 protein results in increased expression of and results in increased phosphorylation of JUN protein] | 23240583 |
| C581040 | KU-32 compound | KU-32 compound inhibits the reaction [NRG1 protein results in decreased expression of MPZ protein] | 20711301 |
| D008044 | Linuron | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| D008044 | Linuron | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| D008344 | Maneb | [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NRG1 mRNA | 23017109 |
| D008694 | Methamphetamine | NRG1 gene SNP affects the susceptibility to Methamphetamine | 18316681 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of NRG1 mRNA | 15890375 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NRG1 mRNA | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of NRG1 mRNA | 21678067 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of NRG1 mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of NRG1 mRNA | 21527772 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in increased expression of NRG1 mRNA | 22401849 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of NRG1 protein | 24625837 |
| C583365 | N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide | "N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of NRG1 mRNA" | 29244179 |
| C554954 | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride | N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride results in increased expression of NRG1 mRNA | 28174063 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of NRG1 mRNA" | 25554681 |
| C031721 | naphthalene | naphthalene analog results in increased expression of NRG1 mRNA | 24976557 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of NRG1 mRNA | 25380136 |
| C461488 | N-benzylpiperazine | N-benzylpiperazine results in increased expression of NRG1 mRNA | 26821219 |
| D009532 | Nickel | Nickel results in increased expression of NRG1 mRNA | 24768652|2558310 |
| C119536 | nickel acetate | nickel acetate results in decreased expression of and results in decreased phosphorylation of NRG1 protein | 22210268 |
| C119536 | nickel acetate | nickel acetate results in decreased expression of NRG1 mRNA | 22210268 |
| C022838 | nickel chloride | nickel chloride results in increased expression of NRG1 mRNA | 17312168 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of NRG1 mRNA | 22714537 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of NRG1 mRNA | 17616710 |
| C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of NRG1 mRNA | 19716841 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of NRG1 mRNA | 22124623 |
| C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA | 25607892 |
| C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA | 25607892 |
| D009966 | Orphenadrine | Orphenadrine affects the expression of NRG1 mRNA | 23665939 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of NRG1 mRNA | 25729387 |
| D010126 | Ozone | Ozone results in increased expression of NRG1 mRNA | 16716893 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of NRG1 mRNA | 26272509 |
| D010269 | Paraquat | [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of NRG1 mRNA | 23017109 |
| D010278 | Parathion | Parathion results in increased methylation of NRG1 promoter | 22847954 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of NRG1 mRNA | 25868421 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of NRG1 mRNA | 19162173 |
| D015232 | Dinoprostone | Dinoprostone inhibits the reaction [Celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA]] | 16357062 |
| D015232 | Dinoprostone | Dinoprostone results in increased expression of NRG1 mRNA | 16357062 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of NRG1 mRNA | 19159669 |
| D010656 | Phenylephrine | Phenylephrine results in decreased expression of NRG1 mRNA | 16698793 |
| D010656 | Phenylephrine | Phenylephrine results in decreased expression of NRG1 protein | 16698793 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of NRG1 mRNA | 26272509 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of NRG1 mRNA | 15890375 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of NRG1 mRNA | 17950772 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NRG1 mRNA] | 17950772 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NRG1 mRNA | 15890375|1916217 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NRG1 mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of NRG1 mRNA | 22079256 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of NRG1 mRNA | 23608068 |
| C045362 | prochloraz | prochloraz results in increased expression of NRG1 mRNA | 21470553 |
| C045362 | prochloraz | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| C045362 | prochloraz | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| C035988 | procymidone | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| C035988 | procymidone | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| D011374 | Progesterone | NRG1 protein promotes the reaction [AREG protein results in increased abundance of Progesterone] | 21047912 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of NRG1 mRNA | 26079696 |
| C006068 | propylparaben | NRG1 protein promotes the reaction [propylparaben results in increased expression of MYC mRNA] | 26502914 |
| C006068 | propylparaben | propylparaben promotes the reaction [NRG1 protein results in increased expression of MYC mRNA] | 26502914 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of NRG1 mRNA | 24780913 |
| C043680 | ptaquiloside | [ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA | 23274088 |
| C107773 | pterostilbene | pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 mRNA] | 19617202 |
| C107773 | pterostilbene | pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | 19617202 |
| C107773 | pterostilbene | pterostilbene results in decreased susceptibility to NRG1 protein alternative form | 19617202 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of NRG1 mRNA | 27029645 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | 17651959 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK1 protein] | 17651959 |
| C059514 | resveratrol | resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK3 protein] | 17651959 |
| C059514 | resveratrol | resveratrol results in decreased expression of NRG1 mRNA | 12002526 |
| D018967 | Risperidone | Risperidone results in increased expression of NRG1 protein | 26961615 |
| C093642 | SB 203580 | SB 203580 results in decreased susceptibility to NRG1 protein alternative form | 19617202 |
| C115461 | SC 560 | SC 560 results in decreased expression of NRG1 mRNA | 14633654 |
| C410733 | scriptaid | scriptaid affects the expression of NRG1 mRNA | 18813790 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine affects the expression of NRG1 mRNA" | 24160326 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of NRG1 mRNA | 25895662 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of NRG1 mRNA | 25351596 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of NRG1 gene | 28589171 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of NRG1 mRNA | 22561333|2599309 |
| D018038 | Sodium Selenite | [ptaquiloside co-treated with Sodium Selenite] results in increased expression of NRG1 mRNA | 23274088 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of NRG1 mRNA | 23274088 |
| D012999 | Soman | Soman results in increased expression of NRG1 mRNA | 19281266 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [[NRG1 protein co-treated with Estradiol] results in increased expression of MYC protein] | 26502914 |
| C012568 | terbufos | terbufos results in increased methylation of NRG1 promoter | 22847954 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A results in increased expression of NRG1 mRNA | 25172293 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of NRG1 mRNA | 23152189 |
| D013749 | Tetrachlorodibenzodioxin | "2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA]" | 21851831 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NRG1 mRNA | 21570461|2637764 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA | 19770486|1993321 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NRG1 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA | 19692669|2095900 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in increased expression of NRG1 mRNA | 28973375 |
| D013755 | Tetradecanoylphorbol Acetate | [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA | 21047912 |
| D013755 | Tetradecanoylphorbol Acetate | U 0126 inhibits the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA] | 21047912 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of NRG1 mRNA | 23411599 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased methylation of NRG1 gene | 26756918 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of NRG1 mRNA | 25729387 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose] | 14711829 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of NRG1 mRNA | 21934132 |
| D014212 | Tretinoin | Tretinoin results in increased expression of NRG1 mRNA | 23724009 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of NRG1 mRNA | 25549359 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of NRG1 mRNA | 24935251|2627250 |
| D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of NRG1 mRNA | 21346803 |
| C057693 | troglitazone | troglitazone results in increased expression of NRG1 mRNA | 19140230 |
| C113580 | U 0126 | NRG1 protein alternative form inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | 15231676 |
| C113580 | U 0126 | NRG1 protein alternative form inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | 15231676 |
| C113580 | U 0126 | U 0126 inhibits the reaction [LHB protein results in decreased expression of NRG1 mRNA] | 23071612 |
| C113580 | U 0126 | U 0126 inhibits the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NRG1 mRNA] | 21047912 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of NRG1 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of NRG1 mRNA | 19101580|2317975 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of NRG1 gene | 29154799 |
| D014638 | Vanadates | Vanadates results in increased expression of NRG1 mRNA | 22714537 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of NRG1 gene | 25560391 |
| C025643 | vinclozolin | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA | 25607892 |
| C025643 | vinclozolin | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA | 25607892 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in decreased expression of NRG1 mRNA | 26272509 |
| D019287 | Zinc Sulfate | Zinc Sulfate affects the expression of and affects the splicing of NRG1 mRNA | 10878590 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of NRG1 mRNA | 24714768 |